In yesterday’s Wall Street session, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) shares traded at $35.70, up 0.11% from the previous session.
AMPH stock price is now -14.98% away from the 50-day moving average and -17.55% away from the 200-day moving average. The market capitalization of the company currently stands at $1.72B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $55, Wells Fargo recently initiated with Equal Weight rating for Amphastar Pharmaceuticals Inc (NASDAQ: AMPH). On March 05, 2024, JP Morgan recently initiated its ‘Overweight’ rating on the stock quoting a target price of $60, while ‘BofA Securities’ rates the stock as ‘Neutral’
In other news, Zhou Rong, SENIOR EVP, PRODUCTION CENTER sold 8,000 shares of the company’s stock on Dec 13 ’24. The stock was sold for $361,840 at an average price of $45.23. Upon completion of the transaction, the SENIOR EVP, PRODUCTION CENTER now directly owns 118,469 shares in the company, valued at $4.23 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 12 ’24, SENIOR EVP, PRODUCTION CENTER Zhou Rong sold 7,000 shares of the business’s stock. A total of $310,975 was realized by selling the stock at an average price of $44.42. This leaves the insider owning 118,469 shares of the company worth $4.23 million. A total of 25.56% of the company’s stock is owned by insiders.
During the past 12 months, Amphastar Pharmaceuticals Inc has had a low of $34.60 and a high of $56.88. As of last week, the company has a debt-to-equity ratio of 0.87, a current ratio of 3.43, and a quick ratio of 2.61. According to the stock market information, the enterprise value for the company is $2095864192, which is based on a 11.88 price-to-earnings ratio, a 1.81 price-to-earnings-growth ratio, and a beta of 0.82. The fifty day moving average price for AMPH is $41.9908 and a two-hundred day moving average price translates $43.30155 for the stock.
The latest earnings results from Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was released for 2024-09-30. The net profit margin was 21.80% and return on equity was 23.85% for AMPH. The company reported revenue of $191.21 million for the quarter, compared to $180.56 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.9 percent. For the current quarter, analysts expect AMPH to generate $192.08M in revenue.
